MTX110
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MTX110, covering 2022-02-25 to 2025-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma [Phase 1]